Article
Functional pathway analysis using SCNP of FLT3 receptor pathway deregulation in AML provides prognostic information independent from mutational status.
PloS one - 1 Jan 2013
Cesano Alessandra, Putta Santosh, Rosen David B, Cohen Aileen C, Gayko Urte, Mathi Kavita, Woronicz John, Hawtin Rachael E, Cripe Larry, Sun Zhuoxin, Tallman Martin S, Paietta Elisabeth
Abstract excerpt
FMS-like tyrosine kinase 3 receptor (FLT3) internal tandem duplication (ITD) mutations result in constitutive activation of this receptor and have been shown to increase the risk of relapse in patients with acute myeloid leukemia (AML); however, substantial heterogeneity in clinical outcomes stil...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
